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C reation of a bidirectional cavopulmonary shunt(BCPS) has become increasingly popular as an
interim step in univentricular repair for several reasons.
First, it abolishes ventricular volume overload, which
can impair ventricular performance. Second, it offers
the opportunity to repair associated lesions (systemic
ventricular outflow tract obstruction, atrioventricular
valve regurgitation, and pulmonary venous obstruc-
tion), which may adversely affect prognosis. Third, the
unique circulation created by BCPS makes the patient’s
physiology simpler, allowing more accurate evaluation
Objectives: Although the arterial oxygen saturation after bidirectional
cavopulmonary shunting should theoretically be homogeneous if addition-
al pulmonary flow is obliterated, the arterial oxygen saturation has been
found to vary in clinical practice. Knowledge of the preoperative and oper-
ative determinants of arterial oxygen saturation early after bidirectional
cavopulmonary shunting may lead to a better understanding of this unique
physiology. 
Methods: Thirty-five patients who underwent bidirectional cavopulmonary
shunting with obliteration of additional pulmonary flow were included in
this study. The arterial oxygen saturation was determined at the 5 time points
over a 48-hour period. Multivariable regression analysis was used to identi-
fy the independent predictors of the arterial oxygen saturation. 
Results: No significant interval changes occurred in the arterial oxygen
saturation during the 48 hours after bidirectional cavopulmonary shunt-
ing, which ranged from 61.6% to 95.6%. There was a significant inverse
correlation between the postoperative superior vena cava pressure and the
arterial oxygen saturation (P = .003). A low arterial oxygen saturation
early after bidirectional cavopulmonary shunting was a predictor of mor-
tality or exclusion from univentricular repair within 24 months (P = .012,
odds ratio = 1.14). Of 11 factors identified by univariable analysis, multiple
regression analysis indicated that age less than 8 months at the time of shunt-
ing (P < .0001) and ventricular volume overload (P = .002) predicted a lower
arterial oxygen saturation after bidirectional cavopulmonary shunting. 
Conclusions: Even without additional sources of pulmonary blood flow, sev-
eral preoperative factors, including younger age and severe ventricular volume
overload, predicted a decrease in the arterial oxygen saturation early after bidi-
rectional cavopulmonary shunting. This, in turn, predicted poor outcome dur-
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Table I.  Patient demographic and operative characteristics
Variables n SaO2 P value
Sex .14
Male 19 83.7 ± 8.9
Female 16 79.1 ± 8.8 
Age at BCPS <.0001*
≥8 mo 29 84.5 ± 6.7
<8 mo 6 67.6 ± 4.8 
Weight at BCPS .002*
≥7 kg 27 84.1 ± 6.7
<7 kg 8 73.2 ± 11.1 
Height at BCPS .18
≥70 cm 25 82.9 ± 7.2
<70 cm 10 78.3 ± 12.4 
Body surface area at BCPS .045*
≥0.35 m2 27 83.2 ± 7.3
< 0.35 m2 8 76.0 ± 12.3 
Heterotaxy >.2
Present 20 80.7 ± 9.2
Absent 15 82.8 ± 9.0 
Urgency for BCPS .027*
Elective 23 84.0 ± 7.8
Urgent 12 77.0 ± 9.8 
Morphology of the atrioventricular valve .018*
Double-inlet or tricuspid atresia 15 85.7 ± 6.6
Common-inlet or mitral atresia 20 78.5 ± 9.5 
Associated major aortopulmonary collateral artery >.2
Present 2 81.5 ± 8.4
Absent 33 81.6 ± 9.2
Pulmonary flow from systemic arteries .009*
Present 25 84.1 ± 8.2
Absent 10 75.5 ± 8.4 
Atrioventricular valve regurgitation .14
Moderate or massive 10 78.0 ± 9.3
Mild or less 25 83.0 ± 8.7 
Ventricular volume overload .005*
Greater 12 75.6 ± 10.2
Lesser 23 84.3 ± 7.1 
Previous operation(s) .100*
Yes 26 83.1 ± 9.3
No 9 77.3 ± 7.1 
Previous operation(s) through a lateral thoracotomy .14
Yes 23 83.2 ± 9.2
No 12 78.4 ± 8.2 
Pulmonary vein obstruction .050*
Present 5 74.6 ± 6.7
Absent 30 82.8 ± 8.9 
Use of cardioplegic cardiac arrest .011*
Yes 18 77.9 ± 9.9
No 17 85.5 ± 6.2 
Aortic crossclamp time .008*
≥20 min 15 77.0 ± 10.7
<20 min 20 85.0 ± 5.8
Application of modified ultrafiltration >.2
Yes 15 82.8 ± 10.2
No 20 80.7 ± 8.2 
Concomitant procedure .12
Yes 22 79.8 ± 9.3
No 13 84.7 ± 7.9 
Bilateral SVC anastomosis >.2
Yes 14 81.8 ± 9.4
No 21 81.4 ± 9.0
The SaO2s are averages during the first 48 hours after BCPS. Pulmonary flow from systemic arteries includes surgically created shunt, patent ductus arteriosus, and
major aortopulmonary collateral arteries. BCPS, Bidirectional cavopulmonary shunt; SaO2, arterial oxygen saturation.
*P < .1.
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of ventricular performance and pulmonary vascular
resistance, which is important for patient selection for
univentricular repair. BCPS, therefore, can be consid-
ered as a screening test to identify patients who would
benefit from univentricular repair. The pulmonary/sys-
temic flow ratio after BCPS theoretically should be
approximately 0.5 if additional pulmonary flow is
obliterated, because the pulmonary blood flow is equal
to the flow to the upper systemic arterial system or the
superior vena cava (SVC) flow.1,2 Arterial blood oxy-
gen saturation (SaO2) in the presence of BCPS is the
weighted average of the oxygen saturation in the infe-
rior vena cava and in the pulmonary veins and should
be relatively constant if the oxygen saturation of the
systemic and pulmonary veins is normal.3 However, the
SaO2 after BCPS often varies in the clinical setting. A
low level of SaO2 can occur early after BCPS, leading
to injury of the brain, heart, liver, and kidneys.
Identifying the determinants of SaO2 early after BCPS
may increase our understanding of the physiology of
this unique circulation, improve the selection of candi-
dates for BCPS, determine the need for additional
blood flow, and improve the management of postoper-
ative oxygenation. This study was therefore performed
to identify the clinical parameters that affect the SaO2
early after BCPS.
Patients and methods 
Patients.  This study included 35 patients with single ven-
tricle physiology undergoing BCPS and concomitant obliter-
ation of additional pulmonary flow between November 1993
and July 1999 at the Keio University Hospital. Patients with
pre-existing myocardial dysfunction necessitating inotropic
support (n = 4), takedown of a univentricular repair to a
BCPS (n = 2), or associated azygos continuation (n = 1)
undergoing total cavopulmonary shunt (Kawashima proce-
dure4) were excluded from this series. There were 19 male
and 16 female patients. The ages at the time of BCPS ranged
from 4 months to 22 years (median, 1.2 years).
Atrioventricular alignment consisted of common inlet (n =
15, 43%), tricuspid atresia or severe stenosis (n = 8, 23%),
double inlet (n = 7, 20%), and mitral atresia or severe steno-
sis (n = 5, 14%). Twenty-six patients (74%) had undergone
previous operative procedure(s), including creation of sys-
temic–pulmonary arterial shunts (22 patients), pulmonary
arterial banding (2 patients), pulmonary vein reconstruction
(2 patients), and pulmonary arterial augmentation (1 patient)
(numbers are not mutually exclusive). All patients were
catheterized before BCPS to assess all sources of pulmonary
blood flow.
BCPS was indicated for a variety of reasons. In 12 patients,
BCPS was performed urgently to treat symptoms. Eight
patients underwent BCPS to treat congestive heart failure,
which was due to excessive pulmonary blood flow or moder-
ate pulmonary overcirculation in the face of atrioventricular
valve regurgitation. In 2 patients, BCPS was performed to
treat the outgrowth of the pulmonary blood flow limited by a
systemic–pulmonary artery shunt or congenital pulmonary
stenosis. Two patients underwent BCPS to treat anoxic spells.
The remaining 23 patients were free of symptoms and under-
went BCPS on an elective basis as an interim part of staged
univentricular repair. 
Operative procedures. The operations were performed by
one of two surgeons (R.A. or T.K.). All procedures were per-
formed through a midline sternotomy and used cardiopul-
monary bypass (average time, 109 ± 41 minutes). Aortic
crossclamping and cardioplegic cardiac arrest were used for
any intracardiac procedures (18 patients; average time, 38 ±
19 minutes). The bypass technique included aortic and bica-
val (or tricaval, if necessary) cannulation and moderate
hypothermia (lowest rectal temperature, 28°C). Conventional
ultrafiltration was used during the entire period of cardiopul-
monary bypass, and modified ultrafiltration was used in 15
patients who underwent surgery after 1996. Twenty-five
patients (71%) had pulmonary flow through the systemic
arteries before BCPS, including surgically created sys-
temic–pulmonary arterial shunts in 22 patients, patent ductus
arteriosus in 10 patients, and major aortopulmonary collater-
al arteries in 2 patients (numbers are not mutually exclusive).
Thirty-two patients (91%) had pulmonary flow through the
ventricles and pulmonary valves (22 patients had both).
All previously created systemic–pulmonary artery shunts
were taken down. The patent ductus arteriosus and major aor-
topulmonary collateral arteries were also obliterated before
the initiation of cardiopulmonary bypass. In 30 patients who
had pulmonary blood flow through the pulmonary valve, this
source was also removed either by ligation of the pulmonary
trunk or by suture closure of the pulmonary valve. Therefore,
the BCPS provided the only source of pulmonary blood flow
at the completion of the operation. All azygos and hemiazy-
gos veins were suture ligated. The unilateral (n = 21) or bilat-
eral (n = 14) SVC was transected 1 cm distal (cephalic) to the
cavoatrial junction. The proximal (cardiac) end was primari-
ly suture closed. A longitudinal incision was made in the
superior aspect of the pulmonary artery, and the cephalic end
of the transected SVC was anastomosed in an end-to-side
fashion with 6-0 continuous polypropylene sutures.
Temporary atrial pacing was performed as necessary.
Concomitant procedures other than the takedown or oblitera-
tion of additional sources of pulmonary blood flow were per-
formed in 22 patients (63%). These procedures included pul-
monary artery augmentation in 12 patients, atrioventricular
valvuloplasty in 7 patients, repair of anomalous pulmonary
venous connections or atrial septectomy for pulmonary con-
gestion in 5 patients, and the Damus-Kaye-Stansel procedure
in 1 patient (numbers are not mutually exclusive). Of the 10
patients with moderate or massive atrioventricular valve
regurgitation, 7 patients underwent reparative procedures. No
reparative procedures on the atrioventricular valve were per-
formed in the remaining 3 patients who had excessive pul-
monary blood flow. 
Anesthesia.  All patients underwent the same anesthesia
protocol. After oral intubation, general anesthesia was main-
tained with fentanyl and pancuronium bromide. A ventilator
(model E100A, Newport Medical Inc, Newport Beach, Calif)
was used in both the operating room and the intensive care
unit. The ventilator settings were very similar between the
patients during the first 12 hours after surgery, including an
inspired oxygen fraction of 1.0, an end-inspiratory pressure
of 20 to 24 mm Hg, an end-expiratory pressure of 3 to 5 mm
Hg, an inspiratory/expiratory phase ratio of 1:2, and a venti-
latory rate of 20 breaths/min. After cardiopulmonary bypass,
all patients received intravenous nitroglycerin (2 to 3 µg ·
kg–1 · min–1), but weaning from cardiopulmonary bypass was
always attempted without inotropic support. Only 10 patients
(29%) required inotropic support. The patients were weaned
from the ventilator, and supplemental oxygen therapy was
continued for at least 3 days. 
Data acquisition and analysis. Medical and surgical
records were reviewed retrospectively. The clinical charac-
teristics of the patients are summarized in Table I.
Preoperative echocardiograms and preoperative cardiac
catheterization findings were available in 35 patients
(100%) and discharge echocardiograms in 31 patients
(89%). Preoperative pulmonary arterial pressure at
catheterization was measured by passage of the catheter
across the pulmonary valve or systemic–pulmonary arteri-
al shunt. Atrioventricular valve regurgitation was graded
as none, trivial, mild, moderate, or massive on the basis of
qualitative assessment of the regurgitant jet by color
Doppler flow mapping and angiography. Ventricular wall
motion was graded as normal or mildly, moderately, or
severely depressed on the basis of qualitative evaluation by
2-dimensional echocardiography and angiography. Greater
ventricular volume overload was defined as moderate or
massive atrioventricular valve regurgitation or a cardiotho-
racic ratio on the chest radiograph of 0.6 or greater. 
Perioperative SaO2 was evaluated by co-oximetry 20 min-
utes, 2 hours, 12 hours, 24 hours, and 48 hours after the dis-
continuation of bypass. At the same time points, the arterial
blood pH, oxygen tension (PaO2), and carbon dioxide tension
(PaCO2) were determined, and the SVC pressure and hemo-
globin concentration were recorded. 
Follow-up was completed in all the patients after 2.6 ± 2.1
years (range, 0.1-5.9 years). Follow-up echocardiograms
were available in 30 patients (86%), and follow-up cardiac
catheterizations were available in 26 patients (74%). All
patients surviving beyond 6 months after BCPS were exam-
ined with both echocardiograms and cardiac catheterization.
The statistical package SPSS for Windows version 9.0.1
(SPSS Inc, Chicago, Ill) was used for all statistical calcula-
tions. The interval changes in SaO2, SVC pressure, atrioven-
tricular valve regurgitation, and ventricular wall motion were
compared by analysis of variance (ANOVA) with repeated
measures or by the Wilcoxon rank test, where appropriate.
Putative factors that may have influenced the average values of
the SaO2 at the 5 time points during the 48 hours after BCPS
were analyzed univariably (Table I). Relationships of the aver-
age SaO2 and normally distributed continuous variables,
including preoperative hemoglobin concentration, preoperative
SaO2, preoperative pulmonary vascular resistance, preoperative
pulmonary arterial pressure, preoperative pulmonary arterial
cross-sectional index,5 cardiopulmonary bypass time, and fluid
balance index during surgery (fluid balance [milliliters] divid-
ed by body surface area [square meters]) were examined by
correlation analysis. Because age at BCPS, weight at BCPS,
height at BCPS, body surface area at BCPS, and aortic cross-
clamp time were not normally distributed even after the loga-
rithmic transformation, these variables were dichotomized by
means of break points after the linearity of the relationship
between each variable and the average SaO2 had been exam-
ined. Differences in the average SaO2 with and without cate-
goric and dichotomized variables were compared by means of
the Student t test. A stepwise forward selection procedure was
then used to develop a multiple regression model predictive of
the average SaO2. Variables that were significant at the .10 level
on the basis of univariable analysis were considered for inclu-
sion in the model. A P value < .05 was required for variables
to remain in the model. Logistic regression was used to deter-
mine the contribution of the SaO2 or the SVC pressure to the
prediction of mortality or exclusion from completion of the
univentricular repair. All continuous values are expressed as
the mean ± 1 standard deviation. 
Results 
Arterial oxygenation. The values for the SaO2, PaO2,
PaCO2, arterial pH, SVC pressure, and hemoglobin con-
centration are summarized in Table II. No significant
interval changes in the SaO2 were noted during the first
48 postoperative hours (ANOVA with repeated mea-
sures), even though the inspired oxygen fraction
decreased from 1.00 ± 0.00 at 20 minutes to 0.62 ± 0.20
at 48 hours. The SaO2 ranged from 61.6% to 95.6%
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Fig 1. Correlation between the average arterial oxygen satu-
ration (SaO2) and average superior vena cava (SVC) pressure
during the first 48 postoperative hours. Circles represent
patients who underwent successful univentricular repair
within 24 months after bidirectional cavopulmonary shunt;
triangles represent patients who did not.
(average for the 5 time points, 81.6% ± 9.0%). Similarly,
the PaO2 showed little change during the 48 hours (aver-
age, 45.1 ± 11.0 mm Hg). The PaCO2 (average, 30.6 ± 4.0
mm Hg), arterial pH (average, 7.48 ± 0.04), and hemo-
globin concentration (average, 13.4 ± 1.2 g/dL) were all
held in a narrow range among the patients during the
first 48 hours after BCPS. The SVC pressure ranged
from 9 mm Hg to 20 mm Hg (average for the 5 time
points, 14.5 ± 2.9 mm Hg). There was a significant
inverse correlation between the postoperative SVC pres-
sure and the SaO2 (r = –0.48, P = .003, Fig 1). 
Univariable analysis revealed that age less than 8
months, weight less than 7 kg, body surface area less
than 0.35 m2, urgent surgery, the presence of common-
inlet or mitral atresia, the absence of pulmonary flow
from systemic arteries before BCPS, greater ventricu-
lar volume overload, no previous operation(s), and pul-
monary vein obstruction were identified as preopera-
tive risk factors for a lower average value of the SaO2 at
the 5 time points during the 48 hours after BCPS (Table
I). The use of cardioplegic cardiac arrest and an aortic
crossclamp time of longer than 20 minutes were iden-
tified as operative risk factors for a lower SaO2. Sex,
height, heterotaxy, the presence of an associated major
aortopulmonary collateral artery, atrioventricular valve
regurgitation, history of a previous operation through a
lateral thoracotomy, the use of modified ultrafiltration,
the use of concomitant procedures, and bilateral SVC
anastomosis did not influence the postoperative SaO2.
None of the continuous variables were identified as sig-
nificant determinants. Of 11 factors identified by uni-
variable analysis, the final model of multiple regression
analysis identified age less than 8 months (non-stan-
dardized coefficient = –15.6, standard error = 2.5,
P < .0001) and greater ventricular volume overload
(non-standardized coefficient = –6.8, standard error =
2.0, P = .002) as predictors of a decreased SaO2 after
BCPS (the intercept = 86.6%, standard error = 2.5).
The regression coefficient of the model including these
2 risk factors was 0.80 (R2 = 0.64). 
Postoperative recovery and follow-up. BCPS and
obliteration of additional pulmonary blood flow were
performed in all of the patients. Nitric oxide inhalation
was required in 4 patients (11%) because of severe
hypoxemia or a severely elevated SVC pressure. Four
(11%) early deaths occurred. Two patients died of
severe hypoxemia (SaO2 < 70%). Nitric oxide inhala-
tion therapy did not improve their hypoxia. One of
these 2 patients was a 5-month-old infant with tricuspid
atresia and an unrestrictive bulboventricular foramen
who underwent BCPS and a Damus-Kaye-Stansel
anastomosis; the other was a 7-month-old patient with
asplenia syndrome and massive common atrioventricu-
lar valve regurgitation who underwent BCPS and a suc-
cessful atrioventricular valvuloplasty confirmed by
postoperative echocardiography. One patient died of
sudden-onset bradycardia after a stable postoperative
recovery. A 6-month-old patient with asplenia syn-
drome had respiratory distress and died after an
uneventful postoperative recovery. Echocardiography
performed at the time of discharge revealed that atrio-
ventricular valve regurgitation had improved signifi-
cantly (P = .014); moderate or massive regurgitation
preoperatively noted in 10 patients improved to mild or
trivial degrees in all but 2 patients. One patient had
residual massive regurgitation after tricuspid valvulo-
plasty with artificial chordae and rent closure. In the
other patient with moderate regurgitation, the degree of
regurgitation remained the same after BCPS.
Ventricular wall motion was similar before and after
BCPS in all of the patients. 
There were 5 late deaths (14%), all occurring
between 2 and 4 months after BCPS. One patient who
died was a 22-year-old patient with asplenia syndrome
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Table II.  Repeated measures of arterial oxygenation and related variables
Preop 20 min 2 h 12 h 24 h 48 h Follow-up
SaO2 (%) 81.7 ± 6.7 81.3 ± 9.8 80.7 ± 10.9 82.9 ± 9.1 81.8 ± 9.1 81.9 ± 8.6 82.9 ± 6.4
PaO2 (mm Hg) 45.7 ± 6.1 45.3 ± 12.5 43.4 ± 13.3 45.9 ± 14.6 45.6 ± 9.0 45.9 ± 11.8 52.1 ± 3.6
PaCO2 (mm Hg) 38.6 ± 4.8 31.0 ± 6.4 27.4 ± 5.1 28.2 ± 5.9 33.2 ± 6.3 33.4 ± 5.9 36.2 ± 5.3
Arterial pH 7.37 ± 0.04 7.46 ± 0.07 7.52 ± 0.08 7.51 ± 0.06 7.45 ± 0.05 7.46 ± 0.04 7.39 ± 0.07
PA/SVC pressure (mm Hg) 16.8 ± 9.6 14.7 ± 3.7 15.9 ± 3.9 14.1 ± 3.1 14.2 ± 3.6 13.3 ± 3.3 10.0 ± 3.3*
Hemoglobin concentration (g/dL) 16.8 ± 2.0 12.4 ± 1.8 12.2 ± 2.0 13.5 ± 1.6 14.0 ± 1.3 14.9 ± 1.3 16.4 ± 1.5†
Repeated measures of arterial oxygen saturation (SaO2), arterial oxygen tension (PaO2), arterial carbon dioxide tension (PaCO2), arterial pH, pulmonary artery or supe-
rior vena cava pressure (PA/SVC), and hemoglobin concentration. The PA/SVC pressure is the SVC pressure at all time points except the preoperative time point,
where the mean pulmonary arterial pressure is used instead. Measurements were compared with repeated-measures analysis of variance.
*Significantly different (P < .001) values when compared with those during the first 48 hours after operation.
†Significantly different (P < .02) values when compared with those during the first 48 hours after operation.
in whom pulmonary artery thrombosis developed,
causing severe hypoxemia. Other causes of late death
included septicemia (n = 2), sudden death (n = 1), and
myocarditis (n = 1). 
At the time of follow-up cardiac catheterization (6.6
± 2.8 months after BCPS), additional sources of pul-
monary blood flow were all completely eliminated.
Pulmonary arteriovenous fistulas were not identified,
although major collateral blood vessels between the
SVC and atrium were identified in 2 patients. None of
the patients had clinically significant pulmonary
venous obstruction (pressure gradient > 5 mm Hg). The
SVC pressure ranged from 4 to 17 mm Hg (average,
10.0 ± 3.3 mm Hg), which was significantly lower than
during the first 48 hours after BCPS (P < .001, ANOVA
with repeated measures). The SaO2 with the patients
breathing room air ranged from 73% to 92% (average,
83.8% ± 4.5%). This value correlated with the SaO2
during the first 48 hours after BCPS (P = .032) and did
not differ from the values during the first 48 hours. The
hemoglobin concentration increased to 16.4 g/dL when
compared with those during the first 48 hours after the
operation.
Of the 35 patients, 20 underwent completion of uni-
ventricular repair by means of a total cavopulmonary
connection at a mean of 10.6 ± 3.9 months (range, 1.5-
19.1 months) after BCPS, although 2 patients required
takedown of the shunt because of severe hypoxemia or
an elevated SVC pressure (>25 mm Hg). All patients
survived the univentricular repair and are in New York
Heart Association functional class II or I. Six patients
could not undergo univentricular repair within 24
months after BCPS. Four of the patients had an indexed
pulmonary vascular resistance of more than 2 Wood
units. One patient had residual massive atrioventricular
valve regurgitation after unsuccessful valvuloplasty.
One patient had a cerebrovascular accident after BCPS.
Logistic regression analysis revealed that a lower SaO2
early after BCPS was a significant predictor of mortal-
ity or exclusion from univentricular repair within 24
months after BCPS (P = .012; odds ratio, 1.14; 95%
confidence interval, 1.02-1.26). The SVC pressure
early after BCPS was not identified as a predictor of
outcome. 
Discussion
Our results demonstrate that physiologic rather than
anatomic factors help to decrease the SaO2 after BCPS.
Young infancy at the time of BCPS was an independent
predictor of a low SaO2 after BCPS, which is in keeping
with previous reports.6 The SVC flow accounts for
49% of the cardiac output in newborn infants, reaches
a maximum contribution of 55% at 2.5 years of age,
and then gradually decreases to the adult value of 35%
by 6.6 years of age.2 Since pulmonary flow is almost
identical to SVC flow after BCPS because there is no
additional source of pulmonary blood flow, the pul-
monary/systemic flow ratio should be age-dependent.
Although an age of 6.6 years or older is a potential risk
factor for a lower SaO2 after BCPS, our series included
only 4 patients who were 6.6 years of age or older. This
may explain why older age was not identified as a risk
factor. In fact, Gross and associates7 explored determi-
nants of increased cyanosis late after BCPS with an
older patient population in which older age was an
independent determinant of a systemic SaO2 of less
than 75% at follow-up catheterization. Young infants
should have a lower SVC flow than older patients,
which may explain the lower SaO2 in this subgroup.
However, there is another possible explanation. Young
infants may have a higher pulmonary vascular resis-
tance, which has been reported to correlate with post-
operative hypoxemia (SaO2 < 75%) early after BCPS.8
In our study, an elevated SVC pressure correlated with
a low SaO2. This can be explained by an elevated SVC
or pulmonary arterial pressure serving as a driving
force to open collaterals of pulmonary arteriovenous or
systemic upper-lower venous channels. In our patients,
myocardial function and atrioventricular valve function
were not impaired, and pulmonary venous obstruction
was either absent or successfully repaired. Pulmonary
vascular resistance is one of the most important deter-
minants of SVC pressure and, therefore, SaO2.
However, preoperative cardiac catheterization with the
Fick method often fails to evaluate pulmonary vascular
resistance accurately before cavopulmonary shunt.9,10
This may explain why the preoperative pulmonary vas-
cular resistance is not an independent risk factor for a
low SaO2. 
A greater preoperative ventricular volume overload
was also an independent predictor of a low SaO2. With
a greater preoperative ventricular volume load, ventric-
ular volume-mass mismatch should be greater early
after BCPS. Ventricular volume-mass mismatch is a
potential cause of impaired ventricular performance.
This is the primary reason for performing a staged
operation for univentricular repair. Although the impact
of ventricular volume-mass mismatch on ventricular
performance has not been studied much in BCPS, it
should occur in BCPS as well. Lower arterial oxygena-
tion may be explained by lower systemic venous oxy-
genation caused by poorer ventricular performance. 
Our observation has several limitations. First, it is
necessary for definition of pathophysiology in BCPS to
determine oxygen saturation in both the upper and
lower systemic venous blood and cardiac output, which
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was not done in our retrospective study. It has been our
policy not to place indwelling catheters in the vessels
that drain into the systemic ventricle to prevent sys-
temic thromboembolic complications. Continuous or
repeated monitoring of the cardiac output after surgery
in small patients has several limitations, including inac-
curacy. Second, the ventilatory status can affect the
cerebral blood flow and, therefore, pulmonary flow
after BCPS.11 However, all of the patients in the present
study were hyperventilated, and the interpatient vari-
ability in the PaCO2 was low (average PaCO2, 30.6 ± 4.0
mm Hg). Third, this study has ignored several anom-
alies that cannot be evaluated. Specifically, a mismatch
between pulmonary perfusion and ventilation can often
develop, causing suboptimal oxygenation after total
cavopulmonary connection.12 In addition, high collat-
eral flows can be encountered at the time of primary
univentricular repair even if primary sources to the pul-
monary artery are removed.13 BCPS can also cause per-
fusion-ventilation mismatch and collateral flows. In
this study, the SaO2 was predicted by 2 risk factors with
an R2 value of 0.64. The remaining could be explained
in part by the presence of these anomalies in pul-
monary physiology.
Despite the limitations discussed above, our observa-
tions have several clinically relevant implications.
First, there has previously been no consensus regarding
whether or not additional pulmonary blood flow should
be added or preserved at BCPS.6-8,14-19 In our study,
decreased arterial oxygenation early after discontinua-
tion of cardiopulmonary bypass in BCPS often persist-
ed for the subsequent 48 hours and was a predictor of
increased 2-year morbidity and mortality. This finding
suggests that use of a revised procedure with the addi-
tion or preservation (reopening) of additional sources
of pulmonary blood flow may be beneficial if the
patient has decreased SaO2 and has a low SVC pressure
early after BCPS. Second, if a patient with none of
these risk factors has an unexpectedly low SaO2, the
cause should be extensively explored. 
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